Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 5. Pindolol (LB-46) therapy for supraventricular arrhythmia: a viable alternative to propranolol in patients with bronchospasm
- 1 September 1979
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 98 (3) , 393-398
- https://doi.org/10.1016/0002-8703(79)90053-x
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 3. Comparative clinical experience and new therapeutic applicationsAmerican Heart Journal, 1979
- Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 2. Physiologic and metabolic effectsAmerican Heart Journal, 1979
- Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 1. Pharmacodynamic and pharmacokinetic propertiesAmerican Heart Journal, 1979
- Selective beta-1 receptor blockade with oral practolol in man. A dose-related phenomenon.Journal of Clinical Investigation, 1975
- Letter: Paradoxical effect of pindolol.BMJ, 1975
- Pharmacodynamic Properties of ??-Adrenergic Receptor Blocking Drugs in ManDrugs, 1974
- Effects of beta-adrenergic blocking drugs on ventilatory function in asthmaticsEuropean Journal of Clinical Pharmacology, 1972
- THE BETA-BLOCKING EFFECT OF PRACTOLOL IN ASTHMATICSThe Lancet, 1970
- Effects of -Adrenergic Receptor Blockade on Airway Conductance and Lung Volume in Normal and Asthmatic SubjectsBMJ, 1969
- THE EFFECT OF PROPRANOLOL ON AIRWAY RESISTANCEBritish Journal of Anaesthesia, 1967